- Home
- Publications
- Publication Search
- Publication Details
Title
Future therapies for chronic hepatitis C
Authors
Keywords
-
Journal
Nature Reviews Gastroenterology & Hepatology
Volume 10, Issue 5, Pages 268-276
Publisher
Springer Nature
Online
2013-02-19
DOI
10.1038/nrgastro.2013.17
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Will Interferon-Free Regimens Prevail?
- (2012) Christoph Welsch et al. GASTROENTEROLOGY
- Anti−Hepatitis C Virus Drugs in Development
- (2012) Esperance A.K. Schaefer et al. GASTROENTEROLOGY
- Sustained virologic response: Is this equivalent to cure of chronic hepatitis C?
- (2012) Leonard B. Seeff HEPATOLOGY
- 13 A 12-WEEK INTERFERON-FREE REGIMEN OF ABT-450/R, ABT-072, AND RIBAVIRIN WAS WELL TOLERATED AND ACHIEVED SUSTAINED VIROLOGIC RESPONSE IN 91% TREATMENT-NAIVE HCV IL28B-CC GENOTYPE-1-INFECTED SUBJECTS
- (2012) E. Lawitz et al. JOURNAL OF HEPATOLOGY
- 1 ATOMIC: 97% RVR FOR PSI-7977 + PEG/RBV × 12 WEEK REGIMEN IN HCV GT1: AN END TO RESPONSE-GUIDED THERAPY?
- (2012) K.V. Kowdlev et al. JOURNAL OF HEPATOLOGY
- 12 HIGH SVR12 WITH 16 WEEKS OF TEGOBUVIR AND GS-9256 WITH PEGINTERFERON-ALFA 2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS
- (2012) D.R. Nelson et al. JOURNAL OF HEPATOLOGY
- 1209 IMPACT OF EARLY RESPONSE DEFINITIONS ON DURATION AND OUTCOME OF TREATMENT WITH BI201335 PLUS PR
- (2012) M. Sulkowski et al. JOURNAL OF HEPATOLOGY
- 1399 12-WEEK INTERFERON-FREE REGIMEN OF ABT-450/R +ABT-333 +RIBAVIRIN ACHIEVED SVR12 IN MORE THAN 90% OF TREATMENT-NAIVE HCV GENOTYPE-1-INFECTED SUBJECTS AND 47% OF PREVIOUS NON-RESPONDERS
- (2012) F. Poordad et al. JOURNAL OF HEPATOLOGY
- 2 TMC435 IN HCV GENOTYPE 1 PATIENTS WHO HAVE FAILED PREVIOUS PEGYLATED INTERFERON/RIBAVIRIN TREATMENT: FINAL SVR24 RESULTS OF THE ASPIRE TRIAL
- (2012) S. Zeuzem et al. JOURNAL OF HEPATOLOGY
- 1113 ELECTRON: ONCE DAILY PSI-7977 PLUS RBV IN HCV GT1/2/3
- (2012) E.J. Gane et al. JOURNAL OF HEPATOLOGY
- 1186 SAFETY AND ANTIVIRAL ACTIVITY OF ABT-267, A NOVEL NS5A INHIBITOR, DURING 3-DAY MONOTHERAPY: FIRST STUDY IN HCV GENOTYPE-1 (GT1)-INFECTED TREATMENT-NAIVE SUBJECTS
- (2012) E. Lawitz et al. JOURNAL OF HEPATOLOGY
- Genetics of IL28B and HCV—response to infection and treatment
- (2012) C. Nelson Hayes et al. Nature Reviews Gastroenterology & Hepatology
- Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
- (2012) Anna S. Lok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistance Analysis and Characterization of a Thiazole Analogue, BP008, as a Potent Hepatitis C Virus NS5A Inhibitor
- (2011) Hui-Mei Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C Virus Infection: A Cure and So Much More
- (2011) B. L. Pearlman et al. CLINICAL INFECTIOUS DISEASES
- Efficacy of the Protease Inhibitor BI 201335, Polymerase Inhibitor BI 207127, and Ribavirin in Patients With Chronic HCV Infection
- (2011) Stefan Zeuzem et al. GASTROENTEROLOGY
- Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1
- (2011) Richard E. Nettles et al. HEPATOLOGY
- 1376 THE ASPIRE TRIAL: TMC435 IN TREATMENT-EXPERIENCED PATIENTS WITH GENOTYPE-1 HCV INFECTION WHO HAVE FAILED PREVIOUS PEGIFN/RBV TREATMENT
- (2011) S. Zeuzem et al. JOURNAL OF HEPATOLOGY
- 66 SILEN-C2: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO P/R
- (2011) M.S. Sulkowski et al. JOURNAL OF HEPATOLOGY
- Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN α-2a/RBV in hepatitis C patients
- (2011) Edward J. Gane et al. JOURNAL OF HEPATOLOGY
- Distinct Functions of NS5A in Hepatitis C Virus RNA Replication Uncovered by Studies with the NS5A Inhibitor BMS-790052
- (2011) R. A. Fridell et al. JOURNAL OF VIROLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- A New Era of Hepatitis C Therapy Begins
- (2011) Donald M. Jensen NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- What Is Killing People with Hepatitis C Virus Infection?
- (2011) Jason Grebely et al. SEMINARS IN LIVER DISEASE
- Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
- (2010) Fasiha Kanwal et al. GASTROENTEROLOGY
- The Institute of Medicine report on viral hepatitis: A call to action
- (2010) Arun J. Sanyal et al. HEPATOLOGY
- Institute of Medicine recommendations for the prevention and control of hepatitis B and C
- (2010) Abigail E. Mitchell et al. HEPATOLOGY
- RG7128 Alone or in Combination with Pegylated Interferon‐α2a and Ribavirin Prevents Hepatitis C Virus (HCV) Replication and Selection of Resistant Variants in HCV‐Infected Patients
- (2010) Sophie Le Pogam et al. JOURNAL OF INFECTIOUS DISEASES
- Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
- (2010) Min Gao et al. NATURE
- Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B
- (2010) Megan H. Powdrill et al. Viruses-Basel
- Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C Patients
- (2009) Henk W. Reesink et al. GASTROENTEROLOGY
- The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naïve hepatitis C patients
- (2009) Robert Flisiak et al. HEPATOLOGY
- Long-term Outcomes After Treatment With Interferon and Ribavirin in HCV Patients
- (2009) Andrew Aronsohn et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- The global burden of hepatitis C
- (2009) Daniel Lavanchy LIVER INTERNATIONAL
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liver and Intestine Transplantation in the United States, 1997–2006
- (2008) R. B. Freeman et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
- Interferon-based therapy for chronic hepatitis C: current and future perspectives
- (2008) Stefan Zeuzem Nature clinical practice. Gastroenterology & hepatology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started